RGEN Q3 2023 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$141M-29.7% YoY

Gross Profit

$37M25.9% margin

Operating Income

$5M3.3% margin

Net Income

$17M12.0% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

-11.3%

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$30M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$526M

Stockholders' Equity

$2.0B

Cash & Equivalents

$631M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$201M	-29.7%
Gross Profit	$37M	$114M	-68.0%
Operating Income	$5M	$53M	-91.1%
Net Income	$17M	$40M	-58.1%

Revenue Segments

Product

$141M100%

Royalty

$36,0000%